MX2009013535A - Empaque de tabletas medicinales. - Google Patents
Empaque de tabletas medicinales.Info
- Publication number
- MX2009013535A MX2009013535A MX2009013535A MX2009013535A MX2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A MX 2009013535 A MX2009013535 A MX 2009013535A
- Authority
- MX
- Mexico
- Prior art keywords
- pack
- medicinal tablets
- tablets
- medicinal
- ester
- Prior art date
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 abstract 1
- 229960001736 buprenorphine Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/18—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
- B65D81/20—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
- B65D81/2069—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mechanical Engineering (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Se describe un empaque oclusivo de oxígeno y agua. El empaque abarca una atmósfera inerte que contiene, tabletas medicinales, en donde las tabletas contienen buprenorfina o una sal o éster de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0711376A GB2450117A (en) | 2007-06-13 | 2007-06-13 | A water- and oxygen-occlusive blister tablet pack |
| PCT/GB2008/001659 WO2008152347A2 (en) | 2007-06-13 | 2008-05-14 | Pack of medicinal tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009013535A true MX2009013535A (es) | 2010-02-22 |
Family
ID=38331999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009013535A MX2009013535A (es) | 2007-06-13 | 2008-05-14 | Empaque de tabletas medicinales. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8697718B2 (es) |
| EP (1) | EP2155139B1 (es) |
| CN (1) | CN101715337A (es) |
| AR (1) | AR066975A1 (es) |
| AU (3) | AU2008263682A1 (es) |
| BR (1) | BRPI0812476A2 (es) |
| CA (1) | CA2690036C (es) |
| CL (1) | CL2008001744A1 (es) |
| ES (1) | ES2626628T3 (es) |
| GB (1) | GB2450117A (es) |
| MX (1) | MX2009013535A (es) |
| NZ (1) | NZ581604A (es) |
| PE (1) | PE20090373A1 (es) |
| TW (1) | TWI527579B (es) |
| WO (1) | WO2008152347A2 (es) |
| ZA (1) | ZA200908588B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS53995B1 (sr) | 2011-09-19 | 2015-10-30 | Orexo Ab | Nove farmaceutske kompozicije, otporne na zloupotrebu, za tretman zavisnosti od opioida |
| CN108079221A (zh) * | 2018-02-27 | 2018-05-29 | 湖南尔康制药股份有限公司 | 一种维c银翘泡腾片 |
| CN108313367A (zh) * | 2018-02-27 | 2018-07-24 | 湖南尔康制药股份有限公司 | 一种充惰性气体包装的维c银翘片 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5549204A (en) * | 1992-02-26 | 1996-08-27 | Toren Consulting Pty. Ltd. | Blister packs |
| JP2736952B2 (ja) * | 1992-09-18 | 1998-04-08 | 小野薬品工業株式会社 | アミジノフェノール誘導体およびその誘導体を有効成分として含有する薬剤 |
| US5858490A (en) * | 1993-06-10 | 1999-01-12 | Nkk Corporation | Film formed from polyethylene-2,6-naphthalate resin, process for producing said film and package using said film |
| CH689305A5 (de) * | 1994-08-23 | 1999-02-15 | Alusuisse Lonza Services Ag | Blisterpackung. |
| US5799463A (en) * | 1996-05-28 | 1998-09-01 | Mitsubishi Gas Chemical Company, Inc. | Method for preservation of article |
| US6592869B2 (en) * | 1999-08-24 | 2003-07-15 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
| PL354872A1 (en) * | 1999-10-23 | 2004-03-08 | Alkaloid Ad | Oral dosage form comprising a salt of morphine or a morphine derivative |
| GB0015617D0 (en) * | 2000-06-26 | 2000-08-16 | Vectura Ltd | Improved preparations for dermal delivery of active substances |
| US7025992B2 (en) * | 2001-02-14 | 2006-04-11 | Gw Pharma Limited | Pharmaceutical formulations |
| EP1241110A1 (en) * | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Dispensing unit for oxygen-sensitive drugs |
| SI21302A (sl) * | 2002-10-11 | 2004-04-30 | LEK farmacevtska dru�ba d.d. | Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino |
| WO2004064809A1 (en) * | 2003-01-22 | 2004-08-05 | Sandoz Ag | Solid pharmaceutical composition comprising ramipril |
| TWI322008B (en) * | 2003-01-31 | 2010-03-21 | Kaneka Corp | Fatigue improving agent including reduced coenzyme q10 |
| CA2553724A1 (en) * | 2004-02-03 | 2005-08-18 | Abbott Laboratories | Aminobenzoxazoles as therapeutic agents |
| ATE412404T1 (de) * | 2004-06-02 | 2008-11-15 | Galephar M F | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon |
| CA2589283A1 (en) * | 2004-12-27 | 2006-07-06 | King Pharmaceuticals Research And Development, Inc. | Oxygen-impervious packaging and methods for storing thyroid hormone |
| TWI318571B (en) * | 2005-06-10 | 2009-12-21 | Lilly Co Eli | Formulation of a thienopyridine platelet aggregation inhibitor |
| US8148356B2 (en) * | 2005-08-24 | 2012-04-03 | Cumberland Pharmaceuticals, Inc. | Acetylcysteine composition and uses therefor |
| DE502005011092D1 (de) * | 2005-10-05 | 2011-04-21 | Berlin Chemie Ag | Pharmazeutische Schutzverpackung |
| WO2007084247A2 (en) * | 2005-12-28 | 2007-07-26 | Alza Corporation | Stable therapeutic formulations |
| EP1993607A4 (en) * | 2006-01-10 | 2012-03-28 | Pipex Inc | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR OBTAINING AND MAINTAINING A TARGETABLE, STABLE COPPER RATE AND PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES RELATED TO SERIAL COPPER RATE |
-
2007
- 2007-06-13 GB GB0711376A patent/GB2450117A/en not_active Withdrawn
-
2008
- 2008-05-14 CA CA2690036A patent/CA2690036C/en not_active Expired - Fee Related
- 2008-05-14 MX MX2009013535A patent/MX2009013535A/es active IP Right Grant
- 2008-05-14 CN CN200880019695A patent/CN101715337A/zh active Pending
- 2008-05-14 WO PCT/GB2008/001659 patent/WO2008152347A2/en not_active Ceased
- 2008-05-14 NZ NZ581604A patent/NZ581604A/xx not_active IP Right Cessation
- 2008-05-14 US US12/664,285 patent/US8697718B2/en not_active Expired - Fee Related
- 2008-05-14 BR BRPI0812476-0A2A patent/BRPI0812476A2/pt not_active Application Discontinuation
- 2008-05-14 ES ES08750593.9T patent/ES2626628T3/es active Active
- 2008-05-14 AU AU2008263682A patent/AU2008263682A1/en not_active Abandoned
- 2008-05-14 EP EP08750593.9A patent/EP2155139B1/en not_active Not-in-force
- 2008-06-11 TW TW097121640A patent/TWI527579B/zh not_active IP Right Cessation
- 2008-06-12 PE PE2008001005A patent/PE20090373A1/es not_active Application Discontinuation
- 2008-06-12 AR ARP080102507A patent/AR066975A1/es unknown
- 2008-06-12 CL CL2008001744A patent/CL2008001744A1/es unknown
-
2009
- 2009-12-03 ZA ZA2009/08588A patent/ZA200908588B/en unknown
-
2014
- 2014-07-09 AU AU2014203766A patent/AU2014203766B2/en not_active Ceased
-
2016
- 2016-05-31 AU AU2016203632A patent/AU2016203632A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008152347A2 (en) | 2008-12-18 |
| US20100292265A1 (en) | 2010-11-18 |
| TWI527579B (zh) | 2016-04-01 |
| CA2690036A1 (en) | 2008-12-18 |
| ZA200908588B (en) | 2011-02-23 |
| US8697718B2 (en) | 2014-04-15 |
| CN101715337A (zh) | 2010-05-26 |
| WO2008152347A3 (en) | 2009-04-23 |
| EP2155139A2 (en) | 2010-02-24 |
| GB0711376D0 (en) | 2007-07-25 |
| CA2690036C (en) | 2016-07-05 |
| AU2014203766A1 (en) | 2014-07-31 |
| TW200911217A (en) | 2009-03-16 |
| AU2008263682A1 (en) | 2008-12-18 |
| GB2450117A (en) | 2008-12-17 |
| AR066975A1 (es) | 2009-09-23 |
| NZ581604A (en) | 2012-08-31 |
| CL2008001744A1 (es) | 2009-05-22 |
| EP2155139B1 (en) | 2017-04-05 |
| PE20090373A1 (es) | 2009-04-01 |
| AU2014203766B2 (en) | 2016-06-09 |
| AU2016203632A1 (en) | 2016-06-23 |
| ES2626628T3 (es) | 2017-07-25 |
| BRPI0812476A2 (pt) | 2014-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI366567B (en) | Bicyclic heterocycles as hiv integrase inhibitors | |
| IL179161A0 (en) | Hiv integrase inhibitors: cyclic pyrimidinone compounds | |
| EP1756069A4 (en) | HIV INTEGRASE INHIBITORS | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| IL177189A0 (en) | Hiv integrase inhibitors | |
| TN2012000195A1 (en) | Solid dispersion of rifaximin | |
| TN2012000248A1 (en) | Novel spiropiperidine compounds | |
| IL177858A0 (en) | Hiv integrase inhibitors | |
| TN2011000291A1 (en) | Purine compounds | |
| SI1948666T1 (sl) | Hiv integrazni inhibitorji | |
| WO2008096736A1 (ja) | ベンゾトリアゾール化合物含有組成物及び該組成物を用いてなる発光素子 | |
| UA107476C2 (uk) | Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів | |
| MX2009013535A (es) | Empaque de tabletas medicinales. | |
| EP1910363A4 (en) | INHIBITORS OF HIV INTEGRASE | |
| WO2008096742A1 (ja) | インダゾール化合物含有組成物及び該組成物を用いてなる発光素子 | |
| AU303806S (en) | Power pack for dentistry applications | |
| PH12013500210A1 (en) | Highly crystalline valsartan | |
| ZA200711048B (en) | Tablet containing hardly soluble active incredient | |
| UA94781C2 (ru) | Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции | |
| PL1865931T3 (pl) | Plaster przezskórny | |
| DE602006008339D1 (en) | Zolpidemtabletten | |
| WO2009054483A1 (ja) | サリューシン-βを含む医薬 | |
| EP1910356A4 (en) | HIV integrase | |
| WO2005074929A3 (en) | Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole | |
| ZA200609935B (en) | Bicyclic heterocycles as HIV integrase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: RB PHARMACEUTICALS LIMITED.* |
|
| FG | Grant or registration |